HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cochlear Implantation

Surgical insertion of an electronic hearing device (COCHLEAR IMPLANTS) with electrodes to the COCHLEAR NERVE in the inner ear to create sound sensation in patients with residual nerve fibers.
Also Known As:
Cochlear Implantations; Cochlear Prosthesis Implantations; Implantation, Cochlear; Implantation, Cochlear Prosthesis; Implantations, Cochlear; Implantations, Cochlear Prosthesis; Prosthesis Implantation, Cochlear; Prosthesis Implantations, Cochlear; Cochlear Prosthesis Implantation
Networked: 2768 relevant articles (182 outcomes, 374 trials/studies)

Relationship Network

Therapy Context: Research Results

Experts

1. Lenarz, Thomas: 32 articles (08/2021 - 11/2002)
2. Roland, J Thomas: 26 articles (11/2021 - 08/2006)
3. Carlson, Matthew L: 25 articles (01/2022 - 08/2011)
4. Mylanus, Emmanuel A M: 23 articles (01/2022 - 11/2004)
5. Sterkers, Olivier: 23 articles (07/2021 - 01/2007)
6. Van de Heyning, Paul: 19 articles (05/2022 - 09/2008)
7. Buchman, Craig A: 18 articles (10/2021 - 08/2004)
8. Grolman, Wilko: 18 articles (01/2021 - 09/2010)
9. Papsin, Blake C: 18 articles (01/2021 - 02/2003)
10. Kameswaran, Mohan: 17 articles (05/2022 - 09/2007)

Related Diseases

1. Hearing Loss (Hearing Impairment)
2. Deafness (Deaf Mutism)
06/01/2017 - "One year after cochlear implantation, most patients with single-sided deafness showed benefits in hearing as measured by validated questionnaires However, not all patients reported a significant improvement in general quality of life. "
01/01/2022 - "This is important to better understand the influence of CH on CI outcomes, and to assess the safety and efficacy of future novel treatments for deafness that will be administered as adjunctive therapies to cochlear implantation. "
01/01/2020 - "For those with single-sided deafness in whom cochlear implantation is contraindicated, bone-conduction implants when compared with no intervention provide clinically important functional gains in hearing thresholds (36-41 dB improvement in pure tone audiometry and 38-56 dB improvement in speech reception threshold, P < .05; GRADE: Moderate) and improve speech perception in noise (signal-to-noise ratio -2.0 vs. 0.6, P < .05 for active percutaneous devices; signal-to-noise ratio improved by 1.3-2.5 dB, P < .05 for active transcutaneous devices; GRADE: Moderate) and hearing-specific quality of life (Abbreviated Profile for Hearing Aid Benefit, ease of communication: 12%-53% vs. 24%-59%; background noise: 18%-48% vs. 33%-79%; listening in reverberant condition: 26%-55% vs. 41%-65%, P < .05 [active percutaneous devices]; ease of communication: 7% vs. 20%; background noise: 46% vs. 69%; listening in reverberant condition: 27% vs. 43%; P < .05 [active transcutaneous devices]; Children's Home Inventory for Listening Difficulties score 7.3 vs. 3.4; P < .05 [passive transcutaneous devices]; GRADE: Moderate). "
02/01/2016 - "Although there were marked variations in the outcome of cochlear implantation, patients with specific deafness gene mutations showed relatively good results. "
02/01/2008 - "Based on the results, our objective is to determine the efficacy of the two applications of cochlear implantation, the first characterized by a shallow electrode insertion and preservation of low-frequency natural hearing for partial deafness, and the second characterized by a very deep electrode insertion used in subjects with severe to profound deafness. "
3. Sensorineural Hearing Loss
4. Tinnitus
5. Otosclerosis

Related Drugs and Biologics

1. Silver Sulfadiazine (SSD)
2. Mitochondrial DNA (mtDNA)
3. Dexamethasone (Maxidex)
4. Steroids
5. Interleukin 1 Receptor Antagonist Protein (Anakinra)
6. Monoamine Oxidase (MAO)
7. Ciprofloxacin (Cipro)
8. Biomarkers (Surrogate Marker)
9. Capsules (Microcapsules)
10. Platinum

Related Therapies and Procedures

1. Hearing Aids (Hearing Aid)
2. Therapeutics
3. Cochlear Implants (Cochlear Implant)
4. Electrodes (Electrode)
5. Stapes Surgery (Stapedectomy)